CN102980996A - Chemiluminescence immunoassay system, as well as method and application thereof - Google Patents

Chemiluminescence immunoassay system, as well as method and application thereof Download PDF

Info

Publication number
CN102980996A
CN102980996A CN2012105932639A CN201210593263A CN102980996A CN 102980996 A CN102980996 A CN 102980996A CN 2012105932639 A CN2012105932639 A CN 2012105932639A CN 201210593263 A CN201210593263 A CN 201210593263A CN 102980996 A CN102980996 A CN 102980996A
Authority
CN
China
Prior art keywords
kapillary
magnetic field
control module
chemiluminescence
magnetic bead
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012105932639A
Other languages
Chinese (zh)
Other versions
CN102980996B (en
Inventor
刘大渔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
He Xin bio tech ltd, Guangdong
Original Assignee
Guangzhou First Peoples Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou First Peoples Hospital filed Critical Guangzhou First Peoples Hospital
Priority to CN201210593263.9A priority Critical patent/CN102980996B/en
Publication of CN102980996A publication Critical patent/CN102980996A/en
Application granted granted Critical
Publication of CN102980996B publication Critical patent/CN102980996B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

The invention discloses a chemiluminescence immunoassay system, as well as a method and an application thereof. The chemiluminescence immunoassay system comprises a fluid control unit as well as a three-dimensional motion sample feeding platform, a temperature control unit, a magnetic field control module and an optical detecting module, wherein the three-dimensional motion sample feeding platform, the temperature control unit, the magnetic field control module and the optical detecting module are connected with each other in sequence; and the fluid control unit is connected with the temperature control unit. The chemiluminescence immunoassay system disclosed by the invention has the advantages as follows: with a capillary tube as a reactor, reagent transportation and reaction are both carried out in a water-in-oil type liquid drop by using a capillary tube liquid drop technology, so that a stable reaction condition is kept, and crossed pollution between samples and reaction suppression caused by surface adsorption are effectively avoided. The chemiluminescence immunoassay system disclosed by the invention has the advantages of small size, high assay speed, high testing flux, automatic operation and flexibility in application and is suitable for analyzing single sample, batch samples and field rapid assay; medical demands of the masses can be preferably satisfied; meanwhile, the purchasing and operation cost of equipment is obviously reduced, and excellent social and economic benefits are obtained.

Description

A kind of chemiluminescence immune assay system and analytical approach and application
Technical field
The invention belongs to medicine equipment and technical field of biological, particularly a kind of chemiluminescence immune assay system and analytical approach and application.
Background technology
Chemiluminescence immune assay (chemiluminescence immunoassay, CLIA) will have highly sensitive chemical luminescent detecting technology and combine with the immune response of high specific, be used for the detection analytical technology of various antigens, haptens, antibody, hormone, enzyme, fatty acid, vitamin and medicine etc.That CLIA has is highly sensitive, high specificity, reagent are cheap, stable reagent and the term of validity (6~18 months), stable fast, wide, the simple to operate automaticity advantages of higher of sensing range of method, all be promoted in fields such as medicine, clinical medicine, food inspection, life science, environment and material science, especially formed the great market of chemiluminescence immune assay in the laboratory medicine field.
Last century, the mid-1970s Arakawe at first reported CLIA, development has become a kind of maturation, advanced ultramicron active substance detection technique so far, it has wide range of applications, being the immune analysis method that at present development is the most ripe and be most widely used, also is present state-of-the-art label immunoassay technology.CLIA sensitivity can be exempted from method, the high several orders of magnitude of fluorescence method than enzyme, can substitute radiommunoassay and enzyme-linked immuno assay fully.Chemiluminescence immunoassay technology is approved by numerous researchists, substitutes just gradually traditional Measurement for Biotechnique.
The chemical illumination immunity analysis instrument device overwhelming majority who uses in the laboratory medicine at present is main equipment, and is although the test flux is higher, expensive and application flexibility is limited.By contrast, microminiaturized chemiluminescence immune assay system have reagent consumption low, analyze advantage quick and easy and simple to handle, be the major transformation to existing operator scheme and equipment.Therefore compare with large-scale chemiluminescence immune assay instrument, microminiaturized chemiluminescence immune assay system price is cheaper, uses more flexibly, is very suitable for outpatient service, emergency treatment and middle-size and small-size medical institutions and uses.The exploitation of this quasi-instrument be clinical examination work in the urgent need to, can effectively reduce testing cost, the Medical need that helps to improve medical service quality and satisfy better broad masses of the people.
Summary of the invention
Primary and foremost purpose of the present invention is to overcome the shortcoming of prior art with not enough, and a kind of chemiluminescence immune assay system is provided.This chemiluminescence immune assay system utilizes kapillary drop technology, with kapillary as reactor, reagent transportation and reaction are all carried out in the water-in-oil type drop, have kept the stable of reaction conditions, have effectively avoided the cross pollution between the sample and the reaction that causes because of adsorption suppresses.
Another object of the present invention is to provide the above-mentioned chemiluminescence immune assay of the utilization analytical approach that system carries out.
A further object of the present invention is to provide the application of described chemiluminescence immune assay system.
Purpose of the present invention is achieved through the following technical solutions: a kind of chemiluminescence immune assay system comprises three-dimensional motion sample introduction platform, temperature control modules, magnetic field control module, fluid control module and optical detecting module; Three-dimensional motion sample introduction platform, temperature control modules, magnetic field control module are connected with optical detecting module and are connected, and the fluid control module is connected with temperature control modules;
Described three-dimensional motion sample introduction platform is comprised of sample/reagent bearing tray, displacement platform, leading screw and drive motor; Sample/reagent bearing tray is arranged at the top of displacement platform, and displacement platform is arranged on the leading screw, and drive motor is arranged at the top of leading screw; Displacement platform can be done along leading screw three-dimensional mobile under drive motor orders about, and displacement platform and sample/reagent bearing tray can carry out three-dimensional motion under the drive motor effect, reagent or sample are transported to temperature control modules;
Described temperature control modules is provided with temperature sensor, temperature controller, relay, the cover plate that connects successively from top to bottom, contains heating aluminium sheet and the heating plate of the chimeric groove of parallel capillary pipe; Temperature sensor is arranged in the heating aluminium sheet, and temperature sensor is connected with temperature controller by wire, and relay is connected with temperature sensor, temperature controller respectively; Temperature control unit is arranged at the left side of sample/reagent bearing tray; Temperature controller is in the digital signal input optical detecting module with analog signal conversion, optical detecting module feeds back to temperature controller with temperature sensor signal, the switch of temperature controller pilot relay, when temperature is lower than setting value, output current to heating plate, and when temperature is higher than setting value, stop output current;
Be provided with kapillary in the chimeric groove of described parallel capillary pipe, described kapillary can be dismantled; Cooperate the movement of three-dimensional motion sample introduction platform, kapillary can be drawn sample or the reagent of placing on the three-dimensional motion sample introduction platform;
Described material capillaceous is preferably plastics, glass or quartz;
Described internal diameter capillaceous is preferably 100~1000 microns, and length is preferably 10~50cm;
Described temperature sensor is preferably the PT-100 temperature sensor;
Described heating aluminium sheet is preferably the heating aluminium sheet that contains 2~96 chimeric grooves of parallel capillary pipe;
Described heating plate is preferably Peltier (Peltier) heating plate;
Described fluid control module is multichannel syringe, and multichannel syringe is connected with the end of described parallel capillary pipe; Three-dimensional motion sample introduction platform is delivered to the capillary sample inlet mouth with sample or reagent, cooperates multichannel syringe to realize suction or the discharge of sample or reagent;
Described fluid control module is preferably the hyperchannel micro syringe;
Described magnetic field control module is arranged at the left side of temperature control modules, comprises two electromagnet that independently, stack up and down, is provided with a slit between two electromagnet, and described kapillary is arranged in the slit; By input and the cut-out of control electric current, two electromagnet can provide unidirectional magnetic field, two way alternate switching field and without magnetic field state; By setting the electromagnet current input, can control location, the unidirectional or bidirectional-movement of magnetic bead in kapillary, thereby realize magnetic bead location, immune compatible reaction and the reaction of magnetic immunochemiluminescence;
Described optical detecting module is arranged at the left side of electromagnet, comprises optical fiber, photoswitch and photomultiplier, and optical fiber is connected with photoswitch, and photoswitch is connected with photomultiplier by simple optical fiber, and optical fiber is corresponding vertical coupled one by one with described kapillary; Photoswitch to photomultiplier, by the continuous signal collection, can be monitored optical signalling in every capillary with the chemiluminescence signal sequence delivery in the kapillary by switching at a high speed simultaneously;
Preferably, described optical detecting module comprises kapillary-optical fiber interface, input optical fibre, photoswitch, output optical fibre and the photomultiplier that connects successively;
Preferably, described temperature control modules, magnetic field control module and optical detecting module are separately fixed on the bearing support;
Displacement platform and sample/reagent bearing tray can carry out three-dimensional motion along leading screw under the drive motor effect, reagent or sample are transported to the capillary sample inlet mouth, cooperates multichannel syringe to realize suction or the discharge of sample or reagent; Input and cut-out by the control electric current, two electromagnet can provide unidirectional magnetic field, two way alternate switching field and without magnetic field state, by setting the input of electromagnet current, location, the unidirectional or bidirectional-movement of magnetic bead in kapillary be can control, thereby magnetic bead location, immune compatible reaction and the reaction of magnetic immunochemiluminescence realized; Photoswitch to photomultiplier, by the continuous signal collection, can be monitored optical signalling in every capillary with the chemiluminescence signal sequence delivery in the kapillary by switching at a high speed simultaneously;
The analytical approach of using above-mentioned chemiluminescence immune assay system to carry out may further comprise the steps:
(1) in kapillary, introduces successively 5 μ L mineral oil, 2 μ L magnetic bead suspensions and 5 μ L sample to be checked, after the liquid section migrates to temperature controlled region with 0.1~5cm/s, magnetic bead suspension and sample to be checked carry out immune response, and immunoreactive condition is 20~40 ℃ of reaction 1~10min;
(2) after the liquid section in the step (1) is finished immune response, move to field regions with 0.1~5cm/s, start the electromagnet of kapillary top, magnetic field intensity is preferably 150mT, and magnetic bead is fixed on the capillary wall;
(3) start micro syringe, behind the solution in the discharge kapillary, introduce 10 μ L cleansing solutions in kapillary, 20~40 ℃ of washing magnetic beads are discharged cleansing solution, repeated washing 2 times; Simultaneously, start the magnetic field control module, magnetic field intensity is preferably 150mT, with 1~100Hz frequency oscillation;
(4) in kapillary, introduce the detection antibody that is marked with horseradish peroxidase or alkaline phosphatase, hatch 1~10min for 20~40 ℃, form antibody-Ag-Ab or Ag-Ab-antibody complex at magnetic bead; Simultaneously, start the magnetic field control module, magnetic field intensity is preferably 150mT, with 1~100Hz frequency oscillation;
(5) start micro syringe, behind the solution in the discharge kapillary, introduce 10 μ L cleansing solutions in kapillary, 20~40 ℃ of washing magnetic beads are discharged cleansing solution, repeated washing 2 times; Simultaneously, start the magnetic field control module, magnetic field intensity is preferably 150mT, with 1~100Hz frequency oscillation;
(6) introduce the reactant liquor that 5 μ L contain chemical luminous substrate in the kapillary, this reactant liquor is with after magnetic bead contacts, and issues biochemical luminescence-producing reaction in the catalysis of horseradish peroxidase or alkaline phosphatase, and reaction conditions is 25~40 ℃ and reacts 0.5~20min; Simultaneously, start the magnetic field control module, magnetic field intensity is preferably 150mT, with 1~100Hz frequency oscillation;
(7) after the liquid section in the step (6) is finished chemiluminescence reaction, migrate to detection zone with 0.1~5cm/s; Chemiluminescence signal is by collecting fiber and transfer to photomultiplier and detect;
In the step (1):
Described magnetic bead surfaces is fixed with capture antibody or capture antigen;
Described magnetic bead suspension adopts following methods to prepare: magnetic bead particles is scattered in the phosphate buffer, and every milliliter of phosphate buffer contains 0.1~0.5g magnetic bead particles, stirs, and obtains the magnetic bead suspension;
Preferably, every milliliter of phosphate buffer contains the 0.25g magnetic bead particles;
Described phosphate buffer is preferably pH7.2,0.1mol/L Na 2HPO 4Aqueous solution;
Described temperature controlled region refers to that kapillary is arranged in the zone of temperature control modules;
Field regions described in the step (2) refers to that kapillary is arranged in the zone of magnetic field control module;
Cleansing solution described in step (3) and (5) is preferably pH7.2,0.1mol/L Na 2HPO 4Aqueous solution;
In the step (6):
Described chemical luminous substrate is luminol/reinforcing agent or 3-(2-spiral diamantane)-4-methoxyl-4-(3-phosphorus oxygen acyl)-phenyl-1, the 2-dioxane;
Described reactant liquor is the luminol-hydrogen peroxide mixed liquor of volume ratio 1:1 or the 3-(2-spiral diamantane) of volume ratio 1:1-4-methoxyl-4-(3-phosphorus oxygen acyl)-phenyl-1,2-dioxane-hydrogen peroxide mixed liquor.
Detection zone described in the step (7) refers to that kapillary is arranged in the zone of optical detecting module;
Described chemiluminescence immune assay system based on kapillary drop technology can be applicable in the fields such as medicine, clinical medicine, food inspection, life science, environment and material science.
Invention mechanism of the present invention is:
A kind of microminiaturized kapillary drop chemiluminescence immune assay system based on the micro-total analysis system theory based on the chemiluminescence immune assay system of kapillary drop technology.This system forms the water-in-oil type drop in parallel kapillary, finish the relevant sequence of operations of antigen-antibody immunoassay by means of the transportation of drop and controlling of magnetic bead.Specifically, this analytic system is utilized hydrophobic property capillaceous, in kapillary, successively introduce oil phase and aqueous phase solution, during the operation of liquid section, under surface tension effects, oil phase infiltrates tube wall, because there are relative motion in water and oil phase, the position of water in service moves forward relatively, forms complete water-in-oil type drop; The cross-contamination issue that the formation of water-in-oil type drop has effectively been avoided evaporation and brought by adsorption.By in kapillary, introducing successively the drop contain various sample and with the auxiliary control in external magnetic field, in kapillary, finishing a series of processes such as sample introduction, antigen-antibody combination, wash-out, luminescence-producing reaction and optical signalling detection.
Heating plate is fixed in heating aluminium sheet below, is inlaid with temperature sensor in the heating aluminium sheet, in order to feed back temperature of heating plate.Temperature sensor is connected with temperature controller, and temperature controller is converted into digital data transmission to computing machine with simulating signal; Computer control software utilize pid algorithm (proportional/integral/derivative algorithm) according to the temperature sense feedback signal to temperature controller, by the temperature controller pilot relay, thereby whether regulate electrical current transports to heating plate.Drop enters temperature controlled region in the kapillary, can realize that fast temperature changes.
Chemiluminescence signal detects the Weak-luminescence detecting device that adopts the system integration.For realizing the dynamic monitoring of drop chemiluminescence signal in the parallel capillary pipe, the present invention adopts a kind of detection method based on optical fiber-photoswitch.Every capillary is provided with optical fiber, is used for gathering chemiluminescence signal and being transferred to photomultiplier detecting.The photoswitch input end is connected with input optical fibre, and its output terminal is connected with output optical fibre, and output optical fibre is transferred to photomultiplier with luminous signal.During detection signal, photoswitch carries out high speed to signals collecting optical fiber and switches, and makes the input end parallel signal gather optical fiber and is communicated with output terminal optical fiber successively.
The principle schematic of immunochemiluminometry is as shown in Figure 2: the first step, with mineral oil, be marked with identification antibody (or antigen) magnetic bead suspension and sample introduce successively kapillary, form the water-in-oil type drop in the motion, identification antibody (or antigen) and antigen to be detected (or antibody) combination; Second step, when the liquid section moved to field regions, magnetic bead was hunted down, and then got rid of waste liquid; In the 3rd step, just mineral oil and contain the liquid section that detects antibody and introduce successively kapillary forms the water-in-oil type drop, detection antibody and antigen to be detected (or antibody) combination when drop moves to field regions in the motion.Get rid of waste liquid after finishing association reaction; In the 4th step, just mineral oil is introduced kapillary successively with the liquid section that contains cleansing solution, forms the water-in-oil type drop in the motion, will then not discharge kapillary in conjunction with detecting antibody elution when drop moves to field regions; The 5th step, just mineral oil is introduced kapillary successively with the liquid section that contains the enzyme luminous substrate, form the water-in-oil type drop in the motion, the enzymatic enzyme luminous substrate that detects mark on the antibody when drop moves to field regions is luminous, the liquid section continued to move to detector area after luminescence-producing reaction finished, and luminous signal is gathered by detecting device in the drop.
The present invention has following advantage and effect with respect to prior art:
(1) immunochemiluminometry provided by the invention system have that volume is little, analysis speed fast, the advantage of test flux height and operation automation, its applying flexible, be suitable for the analysis of single sample and batch sample, be particularly suitable for the analysis of field quick detection.This system is for actual demand and design and development, has function advantage integrated and simple and efficient to handle, significantly reduce purchase and the operating cost of this kind equipment, helped to improve medical service quality, can satisfy better broad masses of the people's Medical need.
(2) chemiluminescence immune analysis method based on kapillary drop technology provided by the invention, reagent transportation and reaction are all carried out in the water-in-oil type drop, keep the stable of reaction conditions, effectively avoided the cross pollution between the sample and the reaction that causes because of adsorption suppresses.
(3) as reactor, not only reagent consumption is little, and with low cost with standard capillary for analytical approach provided by the invention, effectively reduces the cost of instrument production and operation, has good society and economic benefit.
Description of drawings
Fig. 1 is the structural representation of the chemiluminescence immune assay system of embodiment 1.Wherein: 1a drive motor, 1b displacement platform (horizontal component), 2 samples/reagent bearing tray, 3 bearing supports, 4 parallel capillary pipes, 5 heating plates, 6 contain heating aluminium sheet, 7 cover plates, 8 temperature sensors, 9 bidirectional electromagnets, 10 hyperchannel micro syringes, 11 kapillaries-optical fiber interface, 12 input optical fibres, 13 photoswitches, 14 output optical fibres, 15 photomultipliers, 16 temperature controllers, 17 relays of the chimeric groove of kapillary.
Fig. 2 is the principle schematic of immunochemiluminometry.
Fig. 3 is the optical detecting module detailed construction synoptic diagram of chemiluminescence immune assay system, wherein: 4 kapillaries, 12 input optical fibres, 13 photoswitches, 14 output optical fibres, 18 photoswitch openings, 19 utilizing emitted light optical filters, 20 convex lens, 21 pin holes, 15 photomultipliers.
Fig. 4 is the temperature control principle synoptic diagram of chemiluminescence immune assay system, and wherein: 4 kapillaries, 5 heating plates, 6 contain heating aluminium sheet, 7 cover plates, 8PT-100 temperature sensor, 16 temperature controllers, 17 relays, 22 computing machines of the chimeric groove of kapillary.
Fig. 5 is the chemiluminescence detection signal of blood serum sample TNF Beta in 12 passage polytetrafluoroethylene capillaries of embodiment 2.
Fig. 6 is the chemiluminescence detection signal of blood serum sample C hepatitis virus antigen in 2 channel glass kapillaries of embodiment 3.
Fig. 7 is the chemiluminescence detection signal of blood serum sample TNF Beta in 96 passage quartz capillaries of embodiment 4.
Embodiment
The present invention is described in further detail below in conjunction with embodiment and accompanying drawing, but embodiments of the present invention are not limited to this.
Embodiment 1
As shown in Figure 1, a kind of chemiluminescence immune assay system comprises three-dimensional motion sample introduction platform, temperature control modules, magnetic field control module, fluid control module and optical detecting module; Three-dimensional motion sample introduction platform, temperature control modules, magnetic field control module are connected with optical detecting module and are connected, and the fluid control module is connected with temperature control modules;
Described three-dimensional motion sample introduction platform is comprised of sample/reagent bearing tray 2, displacement platform 1b, leading screw and drive motor 1a; Sample/reagent bearing tray 2 is arranged at the top of displacement platform 1b, displacement platform 1b motion under drive motor 1a control;
Cover plate 7, the heating aluminium sheet 6 that contains 96 chimeric grooves of parallel capillary pipe and Peltier (Peltier) heating plate 5 that described temperature control modules is provided with PT-100 temperature sensor 8, temperature controller 16, relay 17, connects successively from top to bottom; PT-100 temperature sensor 8 is arranged in the heating aluminium sheet 6, and PT-100 temperature sensor 8 is connected with temperature controller 16 by wire, and relay 17 is connected with PT-100 temperature sensor 8, temperature controller 16 respectively; Temperature control modules is arranged at the left side of sample/reagent bearing tray 2;
Be provided with parallel capillary pipe 4 in the chimeric groove of kapillary; Material capillaceous is plastics, glass or quartz; Internal diameter capillaceous is 100~1000 microns, and length is 10~50cm;
Parallel capillary pipe 4 can be dismantled;
Described magnetic field control module is arranged at the left side of temperature control modules, comprises between two 9, two electromagnet of electromagnet that independently, stack up and down being provided with a slit, and parallel capillary pipe 4 is arranged in the slit;
Described fluid control module is that 96 passage micro syringes, 10,96 passage micro syringes 10 are connected with the end of kapillary 4;
Described optical detecting module is arranged at the left side of electromagnet 9, comprise the input optical fibre 12, photoswitch 13, output optical fibre 14, utilizing emitted light optical filter 16, convex lens 17, pin hole 18 and the photomultiplier 15 that connect successively, input optical fibre 12 is connected with output optical fibre 15 by opening 14; Input optical fibre 12 kapillaries 4 are corresponding vertical coupled one by one;
Described temperature control modules, magnetic field control module and optical detecting module are separately fixed on the bearing support 3;
Displacement platform and sample/reagent bearing tray can carry out three-dimensional motion along leading screw under the drive motor effect, reagent or sample are transported to the capillary sample inlet mouth, cooperates multichannel syringe to realize suction or the discharge of sample or reagent; Input and cut-out by the control electric current, two electromagnet can provide unidirectional magnetic field, two way alternate switching field and without magnetic field state, by setting the input of electromagnet current, location, the unidirectional or bidirectional-movement of magnetic bead in kapillary be can control, thereby magnetic bead location, immune compatible reaction and the reaction of magnetic immunochemiluminescence realized; Photoswitch to photomultiplier, by the continuous signal collection, can be monitored optical signalling in every capillary with the chemiluminescence signal sequence delivery in the kapillary by switching at a high speed simultaneously.
Embodiment 2
The analytical approach that the chemiluminescence immune assay system of utilization embodiment 1 carries out may further comprise the steps:
(1) in 12 parallel polytetrafluoroethylene capillaries, introduces 5 μ L mineral oil, 2 μ L magnetic bead suspensions and 5 μ L blood serum sample to be checked successively; Used capillary pipe length 10cm, 1000 microns of internal diameters; Used magnetic bead surfaces is fixed with anti-tumor necrosis factor Beta antibody (anti-TNF Beta, mouse-anti people), and magnetic bead particles is dispersed in the phosphate buffer, and the quality percent by volume is 0.25g/mL; Control liquid section migrates to temperature controlled region with 1cm/s speed, and 37 ℃ kept 2 minutes;
(2) move to field regions when drop, start kapillary top electromagnet (magnetic field intensity 150mT), magnetic bead is fixed on capillary wall;
(3) control micro syringe effluent discharge; The control micro syringe is introduced cleansing solution in the kapillary, and (composition is 0.1mol/L Na 2HPO 4, pH7.2), 10 μ L, 37 ℃ of washing magnetic beads 2 times; This process starts the magnetic field control module, and magnetic field intensity is 150mT, with the 10Hz frequency oscillation;
(4) in kapillary, introduce the detection antibody (sheep anti mouse) that is marked with horseradish peroxidase, hatched 2 minutes, and formed antibody-antigen-antibody complex at magnetic bead for 37 ℃; This process starts the magnetic field control module, and magnetic field intensity is 150mT, with the 10Hz frequency oscillation;
(5) (composition is 0.1mol/L Na again to introduce cleansing solution in the kapillary 2HPO 4, pH7.2), 10 μ L, 37 ℃ of washing magnetic beads 2 times; This process starts the magnetic field control module, and magnetic field intensity is 150mT, with the 10Hz frequency oscillation;
(6) in kapillary, introduce reactant liquor (1:1 luminol/reinforcing agent-superoxol) the 5 μ L that contain chemical luminous substrate, until it with after magnetic bead contacts, catalysis at horseradish peroxidase issues biochemical luminescence-producing reaction, and reaction conditions is 37 ℃, and the reaction time is 2 minutes; This process starts the magnetic field control module, and magnetic field intensity is 150mT, with the 10Hz frequency oscillation;
(7) control liquid section is moved to detection zone with 1cm/s speed; Chemiluminescence signal is by the collecting fiber of kapillary below and transfer to photomultiplier and detect;
Testing result when the reactant liquor section arrives detection zone, can detect the chemiluminescence signal in 12 capillaries as shown in Figure 5 simultaneously.
Embodiment 3
The analytical approach that the chemiluminescence immune assay system of utilization embodiment 1 carries out may further comprise the steps:
(1) in 2 parallel glass kapillaries, introduces 5 μ L mineral oil, 2 μ L magnetic bead suspensions and 5 μ L blood serum sample to be checked successively; Used capillary pipe length 50cm, 500 microns of internal diameters; Used magnetic bead surfaces is fixed with C hepatitis virus antigen, and magnetic bead particles is dispersed in the phosphate buffer, and the quality percent by volume is 0.1g/mL; Control liquid section migrates to temperature controlled region with 1cm/s speed, 20 ℃ of lower maintenances 10 minutes;
(2) move to field regions when drop, start kapillary top electromagnet (magnetic field intensity 150mT), magnetic bead is fixed on capillary wall;
(3) control micro syringe effluent discharge; The control micro syringe is introduced cleansing solution in the kapillary, and (composition is 0.1mol/L Na 2HPO 4, pH7.2), 10 μ L, 37 ℃ of washing magnetic beads 2 times; This process starts the magnetic field control module, and magnetic field intensity is 150mT, with the 1Hz frequency oscillation;
(4) in kapillary, introduce the detection antibody (goat-anti people) that is marked with alkaline phosphatase, hatched 2 minutes, and formed Ag-Ab-antibody complex at magnetic bead for 37 ℃; This process starts the magnetic field control module, and magnetic field intensity is 150mT, with the 100Hz frequency oscillation;
(5) (composition is 0.1mol/L Na again to introduce cleansing solution in the kapillary 2HPO 4, pH7.2), 10 μ L, 37 ℃ of washing magnetic beads 2 times; This process starts the magnetic field control module, and magnetic field intensity is 150mT, with the 1Hz frequency oscillation;
(6) in kapillary, introduce the reactant liquor (3-(2-spiral diamantane)-4-methoxyl-4-(3-phosphorus oxygen acyl)-phenyl-1 that contains chemical luminous substrate, the 2-dioxane, AMPPD) 5 μ L, until it with after magnetic bead contacts, catalysis at alkaline phosphatase issues biochemical luminescence-producing reaction, reaction conditions is 25 ℃, and the reaction time is 20 minutes; This process starts the magnetic field control module, and magnetic field intensity is 150mT, with the 100Hz frequency oscillation;
(7) control liquid section is moved to detection zone with 0.1cm/s speed; Chemiluminescence signal is by the collecting fiber of kapillary below and transfer to photomultiplier and detect;
Testing result when the reactant liquor section arrives detection zone, can detect the chemiluminescence signal in 2 capillaries as shown in Figure 6 simultaneously.
Embodiment 4
The analytical approach that the chemiluminescence immune assay system of utilization embodiment 1 carries out may further comprise the steps:
(1) in 96 parallel quartz capillaries, introduces 5 μ L mineral oil, 2 μ L magnetic bead suspensions and 5 μ L blood serum sample to be checked successively; Used capillary pipe length 25cm, 100 microns of internal diameters; Used magnetic bead surfaces is fixed with anti-TNF Beta antibody, the mouse-anti people, and magnetic bead particles is dispersed in the phosphate buffer, and the quality percent by volume is 0.5g/mL; Control liquid section migrates to temperature controlled region with 1cm/s speed, and 40 ℃ kept 1 minute;
(2) move to field regions when drop, start kapillary top electromagnet (magnetic field intensity 150mT), magnetic bead is fixed on capillary wall;
(3) control micro syringe effluent discharge; The control micro syringe is introduced cleansing solution in the kapillary, and (composition is 0.1mol/L Na 2HPO 4, pH7.2), 10 μ L, 37 ℃ of washing magnetic beads 2 times; This process starts the magnetic field control module, and magnetic field intensity is 150mT, with the 1Hz frequency oscillation;
(4) in kapillary, introduce the detection antibody (anti-human TNF Beta, sheep anti mouse) that is marked with horseradish peroxidase, hatched 2 minutes, and formed antibody-antigen-antibody complex at magnetic bead for 37 ℃; This process starts the magnetic field control module, and magnetic field intensity is 150mT, with the 1Hz frequency oscillation;
(5) (composition is 0.1mol/L Na again to introduce cleansing solution in the kapillary 2HPO 4, pH7.2), 10 μ L, 37 ℃ of washing magnetic beads 2 times; This process starts the magnetic field control module, and magnetic field intensity is 150mT, with the 1Hz frequency oscillation;
(6) in kapillary, introduce reactant liquor (1:1 luminol/reinforcing agent-superoxol) the 5 μ L that contain chemical luminous substrate, until it with after magnetic bead contacts, catalysis at horseradish peroxidase issues biochemical luminescence-producing reaction, and reaction conditions is 40 ℃, and the reaction time is 30 seconds; This process starts the magnetic field control module, and magnetic field intensity is 150mT, with the 1Hz frequency oscillation;
(7) control liquid section is moved to detection zone with 5cm/s speed; Chemiluminescence signal is by the collecting fiber of kapillary below and transfer to photomultiplier and detect;
Testing result when the reactant liquor section arrives detection zone, can detect the chemiluminescence signal in 96 capillaries as shown in Figure 7 simultaneously.
Above-described embodiment is the better embodiment of the present invention; but embodiments of the present invention are not restricted to the described embodiments; other any do not deviate from change, the modification done under Spirit Essence of the present invention and the principle, substitutes, combination, simplify; all should be the substitute mode of equivalence, be included within protection scope of the present invention.

Claims (10)

1. a chemiluminescence immune assay system is characterized in that comprising three-dimensional motion sample introduction platform, temperature control modules, magnetic field control module, fluid control module and optical detecting module; Three-dimensional motion sample introduction platform, temperature control modules, magnetic field control module are connected with optical detecting module and are connected, and the fluid control module is connected with temperature control modules;
Described three-dimensional motion sample introduction platform is comprised of sample/reagent bearing tray, displacement platform, leading screw and drive motor; Sample/reagent bearing tray is arranged at the top of displacement platform, and displacement platform is arranged on the leading screw, and drive motor is arranged at the top of leading screw;
Described temperature control modules is provided with temperature sensor, temperature controller, relay, the cover plate that connects successively from top to bottom, contains heating aluminium sheet and the heating plate of the chimeric groove of parallel capillary pipe; Temperature sensor is arranged in the heating aluminium sheet, and temperature sensor is connected with temperature controller by wire, and relay is connected with temperature sensor, temperature controller respectively; Temperature control unit is arranged at the left side of sample/reagent bearing tray; Be provided with kapillary in the chimeric groove of described parallel capillary pipe;
Described fluid control module is multichannel syringe, and multichannel syringe is connected with described end capillaceous;
Described magnetic field control module is arranged at the left side of temperature control modules, comprises two electromagnet that independently, stack up and down, is provided with a slit between two electromagnet, and described kapillary is arranged in the slit;
Described optical detecting module is arranged at the left side of electromagnet, comprises optical fiber, photoswitch and photomultiplier, and optical fiber is connected with photoswitch, and photoswitch is connected with photomultiplier by simple optical fiber, and optical fiber is corresponding vertical coupled one by one with described kapillary.
2. chemiluminescence immune assay according to claim 1 system, it is characterized in that: described material capillaceous is plastics, glass or quartz.
3. chemiluminescence immune assay according to claim 1 system, it is characterized in that: described internal diameter capillaceous is 100~1000 microns, length is 10~50cm.
4. chemiluminescence immune assay according to claim 1 system, it is characterized in that: described heating aluminium sheet is the heating aluminium sheet that contains 2~96 chimeric grooves of parallel capillary pipe.
5. chemiluminescence immune assay according to claim 1 system, it is characterized in that: described optical detecting module comprises kapillary-optical fiber interface, input optical fibre, photoswitch, output optical fibre and the photomultiplier that connects successively.
6. chemiluminescence immune assay according to claim 1 system, it is characterized in that: described fluid control module is the hyperchannel micro syringe.
7. chemiluminescence immune assay according to claim 1 system, it is characterized in that: described temperature control modules, magnetic field control module and optical detecting module are separately fixed on the bearing support.
8. the analytical approach of using each described chemiluminescence immune assay system of claim 1~7 to carry out is characterized in that may further comprise the steps:
(1) in kapillary, introduces successively 5 μ L mineral oil, 2 μ L magnetic bead suspensions and 5 μ L sample to be checked, after the liquid section migrates to temperature controlled region with 0.1~5cm/s, magnetic bead suspension and sample to be checked carry out immune response, and immunoreactive condition is 20~40 ℃ of reaction 1~10min;
(2) after the liquid section in the step (1) is finished immune response, move to field regions with 0.1~5cm/s, start the electromagnet of kapillary top, magnetic field intensity is 150mT, and magnetic bead is fixed on the capillary wall;
(3) start micro syringe, behind the solution in the discharge kapillary, introduce 10 μ L cleansing solutions in kapillary, 20~40 ℃ of washing magnetic beads are discharged cleansing solution, repeated washing 2 times; Simultaneously, start the magnetic field control module, magnetic field intensity is 150mT, with 1~100Hz frequency oscillation;
(4) in kapillary, introduce the detection antibody that is marked with horseradish peroxidase or alkaline phosphatase, hatch 1~10min for 20~40 ℃, form antibody-Ag-Ab or Ag-Ab-antibody complex at magnetic bead; Simultaneously, start the magnetic field control module, magnetic field intensity is 150mT, with 1~100Hz frequency oscillation;
(5) start micro syringe, behind the solution in the discharge kapillary, introduce 10 μ L cleansing solutions in kapillary, 20~40 ℃ of washing magnetic beads are discharged cleansing solution, repeated washing 2 times; Simultaneously, start the magnetic field control module, magnetic field intensity is 150mT, with 1~100Hz frequency oscillation;
(6) introduce the reactant liquor that 5 μ L contain chemical luminous substrate in the kapillary, this reactant liquor is with after magnetic bead contacts, and issues biochemical luminescence-producing reaction in the catalysis of horseradish peroxidase or alkaline phosphatase, and reaction conditions is 25~40 ℃ and reacts 0.5~20min; Simultaneously, start the magnetic field control module, magnetic field intensity is 150mT, with 1~100Hz frequency oscillation;
(7) after the liquid section in the step (6) is finished chemiluminescence reaction, migrate to detection zone with 0.1~5cm/s; Chemiluminescence signal is by collecting fiber and transfer to photomultiplier and detect.
9. the chemiluminescence immune assay according to claim 8 system analytical approach of carrying out is characterized in that:
In the step (1):
Described magnetic bead surfaces is fixed with capture antibody or capture antigen;
Described magnetic bead suspension adopts following methods to prepare: magnetic bead particles is scattered in the phosphate buffer, and every milliliter of phosphate buffer contains 0.1~0.5g magnetic bead particles, stirs, and obtains the magnetic bead suspension;
Cleansing solution described in step (3) and (5) is pH7.2,0.1mol/L Na 2HPO 4Aqueous solution;
In the step (6):
Described chemical luminous substrate is luminol/reinforcing agent or 3-(2-spiral diamantane)-4-methoxyl-4-(3-phosphorus oxygen acyl)-phenyl-1, the 2-dioxane;
Described reactant liquor is the luminol-hydrogen peroxide mixed liquor of volume ratio 1:1 or the 3-(2-spiral diamantane) of volume ratio 1:1-4-methoxyl-4-(3-phosphorus oxygen acyl)-phenyl-1,2-dioxane-hydrogen peroxide mixed liquor.
10. the application of each described chemiluminescence immune assay system of claim 1~7 is characterized in that: described chemiluminescence immune assay system uses in medicine, clinical medicine, food inspection, life science, environment or material science.
CN201210593263.9A 2012-12-31 2012-12-31 Chemiluminescence immunoassay system, as well as method and application thereof Active CN102980996B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210593263.9A CN102980996B (en) 2012-12-31 2012-12-31 Chemiluminescence immunoassay system, as well as method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210593263.9A CN102980996B (en) 2012-12-31 2012-12-31 Chemiluminescence immunoassay system, as well as method and application thereof

Publications (2)

Publication Number Publication Date
CN102980996A true CN102980996A (en) 2013-03-20
CN102980996B CN102980996B (en) 2014-09-10

Family

ID=47855213

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210593263.9A Active CN102980996B (en) 2012-12-31 2012-12-31 Chemiluminescence immunoassay system, as well as method and application thereof

Country Status (1)

Country Link
CN (1) CN102980996B (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103409317A (en) * 2013-07-23 2013-11-27 广州市第一人民医院 Capillary bioanalysis system, and analytical method and applications thereof
CN103713119A (en) * 2013-12-31 2014-04-09 上海科华生物工程股份有限公司 Kit for detecting performance of full-automatic chemiluminescence immunoassay instrument
CN104568755A (en) * 2014-12-29 2015-04-29 苏州长光华医生物医学工程有限公司 Optical fiber conduction device in chemical light emission measuring chamber
CN104949943A (en) * 2014-03-25 2015-09-30 上海执诚生物科技有限公司 Quick biological sample detection method
CN105246190A (en) * 2015-09-02 2016-01-13 深圳市新产业生物医学工程股份有限公司 Standard light source and chemiluminescence immunity analyzer using standard light source
CN106018403A (en) * 2016-05-12 2016-10-12 刘马禾 Light absorption detector of array capillary electrophoresis apparatus and detection method
CN107976402A (en) * 2017-10-19 2018-05-01 广州市第人民医院 It is a kind of based on the modularization bio-analysis system of droplet array chip and its application
CN108593944A (en) * 2018-03-22 2018-09-28 广州市第人民医院(广州消化疾病中心、广州医科大学附属市人民医院、华南理工大学附属第二医院) Liquid drop chip immunoassay system and method
CN109444411A (en) * 2018-10-26 2019-03-08 成都普利泰生物科技有限公司 A kind of canine parvovirus antibody chemical luminescence immue quantitative detection reagent box
CN109709349A (en) * 2019-03-07 2019-05-03 南京迪格诺斯生物技术有限公司 A kind of chemiluminescence immunoassay system
CN109718877A (en) * 2019-01-07 2019-05-07 东莞东阳光科研发有限公司 A kind of centrifuge disc type micro-fluidic chip and its application method
CN110702907A (en) * 2019-10-21 2020-01-17 郑州安图生物工程股份有限公司 Enzymatic chemiluminescence immunoassay method for reducing self background of luminescent substrate
CN116539871A (en) * 2023-05-29 2023-08-04 北京万泰生物药业股份有限公司 Chemiluminescence measuring device based on microfluidics

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1087223A1 (en) * 1998-06-12 2001-03-28 Asahi Kasei Kogyo Kabushiki Kaisha Analyzer
JP2003085613A (en) * 2001-07-04 2003-03-20 Railway Technical Res Inst Printed matter for voucher such as tickets, reagent for discriminating authenticity of the printed matter, authenticity discriminating instrument, authenticity discriminating method, preserving method for authenticity discriminating reagent, and preparing method, contacting method and contacting device of the reagent
CN1664567A (en) * 2005-03-14 2005-09-07 陕西师范大学 Chemiluminescent organophosphorus pesticide residual analyzer and detecting method thereof
CN1814607A (en) * 2004-11-03 2006-08-09 三星电子株式会社 Apparatus and method for purification of nucleic acids by phase separation using laser and beads
CN101021530A (en) * 2007-03-26 2007-08-22 南京大学 Automatic channel resolution chemiluminescent multicomponent immunodetection system and analytical method
CN101038255A (en) * 2007-04-06 2007-09-19 福州大学 Capillary electrophoresis chemiluminescence detector of acridiniumester, acridine sulfonamide and marker thereof, and method thereof
CN201041549Y (en) * 2007-05-10 2008-03-26 沈阳东宇集团股份有限公司 Device for analyzing Nitrogen and oxide based on chemical lighting method
CN101545902A (en) * 2008-03-24 2009-09-30 江苏省肿瘤医院 Automatic sampling distinguishing chemiluminescent multi-component immunological detection system and analysis method of same
CN101692048A (en) * 2009-10-27 2010-04-07 浙江大学 Microchip analysis system for capillary electrophoresis separation and chemiluminescence detection
CN101865912A (en) * 2009-04-14 2010-10-20 南京大学 Fast chemiluminescence immune detection system and analysis method
CN102147406A (en) * 2011-02-14 2011-08-10 四川迈克生物科技股份有限公司 Fully automatic chemical luminescent immune analyzer
CN102183639A (en) * 2011-03-14 2011-09-14 哈尔滨工业大学(威海) Full-automatic chemiluminescence immunity analyzer
CN202166654U (en) * 2011-08-24 2012-03-14 四川迈克生物科技股份有限公司 Full-automatic chemical luminescence immune analyzer
CN102520201A (en) * 2011-12-31 2012-06-27 重庆州泰生物科技有限公司 Automatic chemoluminescence immunity detecting system

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1087223A1 (en) * 1998-06-12 2001-03-28 Asahi Kasei Kogyo Kabushiki Kaisha Analyzer
CN1309769A (en) * 1998-06-12 2001-08-22 旭化成株式会社 Analyzer
JP2003085613A (en) * 2001-07-04 2003-03-20 Railway Technical Res Inst Printed matter for voucher such as tickets, reagent for discriminating authenticity of the printed matter, authenticity discriminating instrument, authenticity discriminating method, preserving method for authenticity discriminating reagent, and preparing method, contacting method and contacting device of the reagent
CN1814607A (en) * 2004-11-03 2006-08-09 三星电子株式会社 Apparatus and method for purification of nucleic acids by phase separation using laser and beads
CN1664567A (en) * 2005-03-14 2005-09-07 陕西师范大学 Chemiluminescent organophosphorus pesticide residual analyzer and detecting method thereof
CN101021530A (en) * 2007-03-26 2007-08-22 南京大学 Automatic channel resolution chemiluminescent multicomponent immunodetection system and analytical method
CN101038255A (en) * 2007-04-06 2007-09-19 福州大学 Capillary electrophoresis chemiluminescence detector of acridiniumester, acridine sulfonamide and marker thereof, and method thereof
CN201041549Y (en) * 2007-05-10 2008-03-26 沈阳东宇集团股份有限公司 Device for analyzing Nitrogen and oxide based on chemical lighting method
CN101545902A (en) * 2008-03-24 2009-09-30 江苏省肿瘤医院 Automatic sampling distinguishing chemiluminescent multi-component immunological detection system and analysis method of same
CN101865912A (en) * 2009-04-14 2010-10-20 南京大学 Fast chemiluminescence immune detection system and analysis method
CN101692048A (en) * 2009-10-27 2010-04-07 浙江大学 Microchip analysis system for capillary electrophoresis separation and chemiluminescence detection
CN102147406A (en) * 2011-02-14 2011-08-10 四川迈克生物科技股份有限公司 Fully automatic chemical luminescent immune analyzer
CN102183639A (en) * 2011-03-14 2011-09-14 哈尔滨工业大学(威海) Full-automatic chemiluminescence immunity analyzer
CN202166654U (en) * 2011-08-24 2012-03-14 四川迈克生物科技股份有限公司 Full-automatic chemical luminescence immune analyzer
CN102520201A (en) * 2011-12-31 2012-06-27 重庆州泰生物科技有限公司 Automatic chemoluminescence immunity detecting system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
张建鹏: "全自动化学发光免疫分析仪", 《中国优秀硕士学位论文全文数据库工程科技Ⅱ辑》 *

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103409317A (en) * 2013-07-23 2013-11-27 广州市第一人民医院 Capillary bioanalysis system, and analytical method and applications thereof
CN103713119A (en) * 2013-12-31 2014-04-09 上海科华生物工程股份有限公司 Kit for detecting performance of full-automatic chemiluminescence immunoassay instrument
CN103713119B (en) * 2013-12-31 2015-06-17 上海科华生物工程股份有限公司 Kit for detecting performance of full-automatic chemiluminescence immunoassay instrument
CN104949943A (en) * 2014-03-25 2015-09-30 上海执诚生物科技有限公司 Quick biological sample detection method
CN104568755A (en) * 2014-12-29 2015-04-29 苏州长光华医生物医学工程有限公司 Optical fiber conduction device in chemical light emission measuring chamber
CN105246190A (en) * 2015-09-02 2016-01-13 深圳市新产业生物医学工程股份有限公司 Standard light source and chemiluminescence immunity analyzer using standard light source
CN106018403B (en) * 2016-05-12 2019-05-21 南京擎科生物科技有限公司 The light absorption detector and detection method of capillary array electrophoresis instrument
CN106018403A (en) * 2016-05-12 2016-10-12 刘马禾 Light absorption detector of array capillary electrophoresis apparatus and detection method
CN107976402A (en) * 2017-10-19 2018-05-01 广州市第人民医院 It is a kind of based on the modularization bio-analysis system of droplet array chip and its application
CN107976402B (en) * 2017-10-19 2021-06-04 广州市第一人民医院 Modular biological analysis system based on liquid drop array chip and application thereof
CN108593944A (en) * 2018-03-22 2018-09-28 广州市第人民医院(广州消化疾病中心、广州医科大学附属市人民医院、华南理工大学附属第二医院) Liquid drop chip immunoassay system and method
CN109444411A (en) * 2018-10-26 2019-03-08 成都普利泰生物科技有限公司 A kind of canine parvovirus antibody chemical luminescence immue quantitative detection reagent box
CN109718877A (en) * 2019-01-07 2019-05-07 东莞东阳光科研发有限公司 A kind of centrifuge disc type micro-fluidic chip and its application method
CN109709349A (en) * 2019-03-07 2019-05-03 南京迪格诺斯生物技术有限公司 A kind of chemiluminescence immunoassay system
CN109709349B (en) * 2019-03-07 2024-02-06 南京仁迈生物科技有限公司 Chemiluminescent immunoassay system
CN110702907A (en) * 2019-10-21 2020-01-17 郑州安图生物工程股份有限公司 Enzymatic chemiluminescence immunoassay method for reducing self background of luminescent substrate
CN110702907B (en) * 2019-10-21 2022-05-03 郑州安图生物工程股份有限公司 Enzymatic chemiluminescence immunoassay method for reducing self background of luminescent substrate
CN116539871A (en) * 2023-05-29 2023-08-04 北京万泰生物药业股份有限公司 Chemiluminescence measuring device based on microfluidics
CN116539871B (en) * 2023-05-29 2023-10-03 北京万泰生物药业股份有限公司 Chemiluminescence measuring device based on microfluidics

Also Published As

Publication number Publication date
CN102980996B (en) 2014-09-10

Similar Documents

Publication Publication Date Title
CN102980996B (en) Chemiluminescence immunoassay system, as well as method and application thereof
CN103409317B (en) Capillary bioanalysis system, and analytical method and applications thereof
CN102147405B (en) Fully automatic biochemical immune analyzer
CN108704677B (en) Microfluidic chip and analytical instrument comprising same
DE69333230T2 (en) AUTOMATIC ANALYSIS SYSTEM WITH PERMANENT AND OPTIONAL ACCESS AND COMPONENTS FOR IT
CN102026727B (en) Particle agglutination in a tip
CN209327360U (en) The micro-fluidic chip for realizing micro whole blood detection is loaded based on two steps
CN202956299U (en) Portable biological aerosol enrichment and quick detection and analysis device
CN103207169B (en) Microfluidic time-resolved fluorescence immunoassay device and application thereof
EP4012410A1 (en) Magnetic particle luminescence micro-fluidic chip for multi-marker detection, and detection device
US20220184619A1 (en) Magnetic particle luminescent micro-fluidic chip for multi-marker detection and detection apparatus
EP3779462A1 (en) Liquid metering device and use thereof
CN103170378A (en) Micro fluidic chip apparatus used for immunization analysis
US8545773B2 (en) Versatile multichannel capillary biosensor system
CN114814261A (en) Automatic chemiluminescence immunoassay chip and detection method thereof
CN110806491B (en) Full-automatic POCT multiple detection liquid phase chip system
CN108212228B (en) Whole blood separation micro-fluidic chip, detection device and whole blood detection method
JPH11242032A (en) Sample analysis device and method
CN102998472B (en) Automatic device for heterogeneous immunization rapid analysis and use method of automatic device
CN201917572U (en) Full-automatic biochemical immunity analysis device
CN103675306B (en) For automated analysis instrument and the system of micro-fluidic immune detection chip
CN101750489A (en) Beta 2-adrenergic receptor stimulant detection method based on microfluidic chip
CN205720248U (en) A kind of fluorescence detection device
CN114113010A (en) Automatic bacteria detection system and method based on digital micro-fluidic
Cai et al. Automation of ELISAs & evaluation of emerging technologies for high-throughput quantitation of protein impurities

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20170811

Address after: 510005, Guangzhou, Guangdong, Guangzhou International Biological Island, spiral four road, No. 1 production zone, fifth story, 501A unit

Patentee after: He Xin bio tech ltd, Guangdong

Address before: 510180 Guangdong city of Guangzhou province Yuexiu District Panfu Road No. 1

Patentee before: Guangzhou City No.1 People's Hospital

TR01 Transfer of patent right